SAMJIN PHARMACEUTICAL CO.,LTD

Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.

005500 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구
Website:: https://www.samjinpharm.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Samjin Pharmaceutical Co., Ltd. is a Korean pharmaceutical company dedicated to the research, development, and manufacturing of treatments to improve human health. The company focuses on creating innovative therapies for diseases with high unmet medical needs, including cardiovascular, respiratory, and gastrointestinal disorders, with an ambition to become a global leader in the field. Through significant investment in R&D, Samjin has developed a diverse portfolio of both prescription and over-the-counter medications. Key products include the antiplatelet drug Plariss, the analgesic Geborin, and the hypercholesterolemia treatment Newstatin R. The company emphasizes securing technological competitiveness and building a robust pipeline of novel drugs.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SAMJIN PHARMACEUTICAL CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-08-29 00:00	Major Shareholding Notification 주식등의대량보유상황보고서(일반)	Korean	126.6 KB
2025-08-27 00:00	Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서	Korean	25.0 KB
2025-08-21 00:00	Major Shareholding Notification 주식등의대량보유상황보고서(일반)	Korean	126.6 KB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
HYUNDAI BIOLAND Co.,Ltd. Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.	South Korea	052260
Icure Pharmaceutical Incorporation Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.	South Korea	175250
Idorsia Ltd Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.	Switzerland	IDIA
IL DONG PHARMACEUTICAL CO., LTD. Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.	South Korea	249420
ILSUNG IS CO., LTD. Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.	South Korea	003120
ILYANG PHARMACEUTICAL CO.,LTD Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.	South Korea	007570
ImmuneOncia Therapeutics, Inc. A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.	South Korea	424870
Immuno-Biological Laboratories Co., Ltd. Develops and supplies immunological reagents and diagnostics for research and drug discovery.	Japan	4570
Incanthera plc Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.	United Kingdom	N/A
Indivior PLC Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.	United Kingdom	INDV